<DOC>
	<DOCNO>NCT00684580</DOCNO>
	<brief_summary>Progress development curative therapy pediatric malignancy result increase number long-term childhood cancer survivor . This protocol mean provide continue review outcome late toxicity patient actively treat previously treat childhood cancer St. Jude Children 's Research Hospital .</brief_summary>
	<brief_title>Protocol For Collecting Data On Patients With Childhood Cancer</brief_title>
	<detailed_description>Previously St. Jude Children 's Research Hospital , monitor report late treatment sequela develop protocol participant occur discretion individual investigator . A formal mechanism coordinate long-term follow-up data collection late cancer-related toxicity exist within institution , central data repository facilitate correlation clinical treatment factor predispose toxicity . Central coordination late effect monitor report St. Jude offer potential benefit facilitate timely communication life-threatening unanticipated late toxicity investigator develop contemporary therapeutic study monitor predisposed survivor may benefit preventive corrective intervention . This study centralize late effect monitor report St. Jude therapeutic study complete auspex one umbrella protocol . This protocol independent research study , rather mean aggregate outcome late effect report regard patient actively treat previously treat St. Jude Children 's Research Hospital diagnosis childhood cancer . Data collect patient include data obtain clinical staff Cancer Registry encounter document medical record provide patient family follow-up form . All monitor patient information provide regard status ( alive/expired ) , relapse , subsequent malignancy , death cause . Clinical outcome , toxicity late effect monitor plan study patient originally enrol collected principal investigator study . Subjects follow After Completion Therapy annual basis 10 year diagnosis ( 10 year completion salvage therapy relapse ) least 18 year age . They undergo specific screen laboratory , diagnostic imaging study , subspecialty consultation medically indicate predispose cancer treatment exposure . At time discharge ACT clinic subject begin annual lifetime follow-up St. Jude Cancer Registry .</detailed_description>
	<criteria>All St Jude patient actively follow treated childhood cancer St. Jude consult patient St. Jude patient permanently discharge care followup Permanently discharge patient include patient electively transfer oncologic care another institution , noncompliant recommend followup leave institution medical advice . Patients refer St. Jude limit care phase 1 protocol .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>St. Jude Alumni</keyword>
	<keyword>St. Jude Life Participants</keyword>
</DOC>